FOCUS Digital Health
Strategy + Smart Evidence + MDR + Market Access + Communications
Digital Health Experts
for Pharma, MedTech, Payers & Service Providers
As consulting professionals, we help small and medium-sized pharmaceutical and medtech companies as well as startups that want to gain a foothold in the healthcare market to pave the way for beneficial digital healthcare innovations.
In a highly regulated market environment with many interest groups, the benefit of a digital innovation is a central success factor. That is why we illuminate the treatment pathways together with our customers and enter into a conversation with all parties involved and reach a common understanding. This creates acceptance for your products!
- From the idea to the competitive product profile: Book a workshop with us.
- Take the next steps towards product development, business model and market success.
- Screen market environment and stakeholders, know competitive situation
- Elaborate unique selling propositions of your product
- Validly assess Unmet Needs for your target group
- Because benefits determine the acceptance of your digital product, we think of benefits as broadly as possible.
- What is the best way to measure benefit: Smart, efficient, convincing!
- What is the benefit of your product for therapists, users and payers?
- Incorporate clinical evidence & real world evidence.
- Identify & use digital biomarkers
- Developing a sustainable business model and identifying the best market access option
- We guide you on the path that best fits your digital product: DiGA, SGV V140a, ZPP certification, DiPA, or B2C market.
- Is your software a medical device (Software as Medical Device = SaMD)?
- Which risk class does your product have and what does this mean for market access routes?
- User requirements, medical purpose, risk classification - we help you on the way to a CE-certified digital medical device.
- We create tailwinds through strategic alliances.
- We find alliance partners with funding, market access to the target group, access to research institution, access to patients and stakeholder groups.